Biologically active native biomatrix composition

A biological matrix and composition technology, applied in the direction of microorganisms, animal/human proteins, biochemical equipment and methods, etc., can solve temperature-sensitive, in vitro BM systems that cannot provide reproducibility of various physiological and pathological processes, and physical performance barriers And other issues

Active Publication Date: 2008-08-20
LIFENET HEALTH
View PDF2 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] Modifications of the original Matrigel formulations have been attempted, including Matrigel supplemented with collagen and Matrigel containing smaller amounts of growth factors, but even these formulations do not provide reliably reproducible in vitro assays for a variety of physiological and pathological processes. BM system
The use of Matrigel has been hampered by the limitations of its physical properties
For example, the physical form of Matrigel (i.e., gel or liquid) is sensitive to temperature, which can create certain limitations for use in in vitro assays
In addition, it should be noted that Matrigel is derived from mouse BM fractions, raising the possibility that studies using this fraction in human model systems could produce artifacts
[0007] The prior art lacks defined, bioactive biological matrices derived from human components

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Biologically active native biomatrix composition
  • Biologically active native biomatrix composition
  • Biologically active native biomatrix composition

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0025] HuBiogel TM the composition of

[0026] Bioactive biomatrix compositions are disclosed. In one embodiment, the biomatrix is ​​derived from human BM tissue (amnion). In one embodiment, the bioorganic matrix contains laminin, collagen I, collagen IV. In alternative embodiments, the matrix may also contain nestin and tenascin. In yet another alternative embodiment, the biomatrix may contain any combination of nestin, tenascin, fibronectin and proteoglycans, such as heparan sulfate proteoglycans. As used in this disclosure, biological activity refers to the presence of extracellular components necessary to maintain viability and allow growth of various cell types under in vitro culture conditions. In one embodiment, the extract contains (by weight) 16-21% laminin, 35-46% collagen I, 19-33% collagen IV, 7.5-14.5% nestin, 3.5-7% tendon Raw egg whites, 0-2% fibronectin and 0-1.3% proteoglycans. The extract is substantially free of growth factors and proteoglycanases (how...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
diameteraaaaaaaaaa
pore sizeaaaaaaaaaa
Login to view more

Abstract

The present disclosure relates to a biologically active biomatrix composition. In one embodiment, the biomatrix composition is derived from human amnions. The biomatrix is termed HuBiogel™. The composition of HuBiogel™ closely mimics naturally occurring basement membrane compositions and is capable of supporting a wide variety of cell types in vitro and in vivo. The HuBiogel™ biomatrix disclosed comprises, in one embodiment, laminin, collagen I, and collagen IV, and may further comprise any combination of the following: entactin, tenascin, fibronectin and proteoglycans. The biomatrix composition is essentially free of endogenous growth factors and proteolytic enzymes. Also described are two- and three-dimensional culture systems and physiological / pathological model systems utilizing the HuBiogel™ compositions. The HuBiogel™ compositions may be modified to contain desired growth stimulants, such as growth factors, polypeptides and organic mall molecules, and may also contain growth inhibitory agents and / or therapeutic agents.

Description

technical field [0001] The present disclosure relates to a bioactive biomatrix composition derived from human amniotic membrane (called HuBiogel TM ). Background technique [0002] The basement membrane (BM) is a continuous structural barrier that separates epithelial tissue from the adjacent stroma. The major components of BM include laminin, collagen types I and IV, nestin, tenascin, and proteoglycans, such as heparan sulfate proteoglycans. Because cells constantly interact with their extracellular environment, BM is involved in many in vivo processes. These processes include physiological processes such as tissue growth and development, bone remodeling, angiogenesis, reproduction, wound healing, and neuronal regeneration, as well as pathological processes such as tumorigenesis / metastasis (including cell migration, invasion, and angiogenesis), angiogenesis Dysfunction, arthritis and aging, and atherosclerosis. During each of these processes, cells interact with and res...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): C12N5/00A61K38/00A61K39/385C07K14/78C07K17/00C12NC12N5/0793
CPCC12N5/0068A61L27/383A61L27/3683C12N2533/92A61L27/3675C07K14/78A61L2430/32A61L27/3604A61K35/30A61L27/52C12N5/0619C12N2533/90A61K39/385A61L27/3878A61K38/18A61K2039/6056A61K38/00A61K2300/00A61K38/02C12N5/0606C12N5/0618
Inventor R·辛格G·西格尔
Owner LIFENET HEALTH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products